| TSE:2269 | 11/18/2025 | Regarding the conclusion of a comprehensive business alliance agreement for joint research with Fukushima Medical University and Fukushima Medical University Translational Research Organization (377KB) | https://www.meiji-seika-pharma.co.jp/pressrelease/2025/detail/pdf/251118_01.pdf |
| TSE:2269 | 11/18/2025 | Japan's first infant formula containing bifidobacteria!Responding to customer needs regarding child nutrition!“Meiji Hohoemi” and “Rakuraku Cube” - A quarter century of bifidobacteria research for babies has borne fruit - Released on November 25, 2025 / N | https://www.meiji.co.jp/corporate/pressrelease/2025/11_06/ |
| TSE:4568 | 11/18/2025 | Received “Forbes JAPAN WOMEN AWARD 2025” | https://www.daiichisankyo.co.jp/sustainability/performance-reports/news/detail/index_7351.html |
| TSE:4578 | 11/18/2025 | Otsuka Chemical introduces controlled polymer technology from Kuraray and invests in new plant | https://www.otsukac.co.jp/topics/Implementation-of-controlled-polymer-technology.html |
| TSE:4886 | 11/18/2025 | November 18, 2025 "Wings of Women" Asuka Pharmaceutical Introducing the 20th anniversary social contribution project "NPO M-STEP"691.72 KB | https://www.aska-pharma.co.jp/news/filedownload.php?name=8cce5364dc4bcf6359bcf9e399d5c95b.pdf |
| ABBV | 11/18/2025 | AbbVie Announces U.S. FDA Approval of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide for Relapsed or Refractory Follicular Lymphoma | https://news.abbvie.com/2025-11-18-AbbVie-Announces-U-S-FDA-Approval-of-EPKINLY-R-epcoritamab-bysp-in-Combination-with-Rituximab-and-Lenalidomide-for-Relapsed-or-Refractory-Follicular-Lymphoma |
| BMY | 11/18/2025 | Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers | https://news.bms.com/news/corporate-financial/2025/Bristol-Myers-Squibb-Announces-Accepted-Amounts-and-Pricing-Terms-of-its-Tender-Offers/default.aspx |
| MRK | 11/18/2025 | Merck Announces First-Quarter 2026 Dividend | https://www.merck.com/news/merck-announces-first-quarter-2026-dividend/ |
| MRK | 11/18/2025 | Merck’s WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint in Phase 2 CADENCE Study in Adults With Combined Post- and Precapillary Pulmonary Hypertension (CpcPH) due to Heart Failure With Preserved Ejection Fraction (HFpEF) | https://www.merck.com/news/mercks-winrevair-sotatercept-csrk-met-primary-endpoint-in-phase-2-cadence-study-in-adults-with-combined-post-and-precapillary-pulmonary-hypertension-cpcph-due-to-heart-failure-w/ |
| TSE:2269 | 11/17/2025 | “Meiji Bulgaria Frozen Yogurt Dessert” first!"Winter Limited" A rich and rich winter treat "Meiji Bulgaria Frozen Yogurt Dessert Winter Thick" will be released sequentially from late November / Nationwide | https://www.meiji.co.jp/corporate/pressrelease/2025/11_05/ |
| TSE:2269 | 11/17/2025 | Three Meiji Group companies have received the highest rating of “Gold” for the third consecutive year in the “PRIDE Index 2025”, an index to evaluate initiatives for LGBTQ+ in the workplace!Meiji Co., Ltd. receives “Rainbow Certification” for 3 consecutiv | https://www.meiji.com/pdf/news/2025/251117_01.pdf |
| TSE:4151 | 11/17/2025 | Kyowa Kirin receives Gold certification for 4th consecutive year in the PRIDE Index, an index evaluating initiatives related to LGBTQ+ (632KB) | https://www.kyowakirin.co.jp/pressroom/news_releases/2025/pdf/20251117_01.pdf |
| TSE:4188 | 11/17/2025 | - Conducted "Survey 2025 on Osaka and Osaka/Doshomachi" - The percentage of people who can read, know about Doshomachi, and recognize it as a "medicine town" has further decreased - A new survey item reveals that the creature that symbolizes Osaka is the | https://www.mt-pharma.co.jp/news/assets/pdf/MTPC251117.pdf |
| TSE:4516 | 11/17/2025 | Information on 2026 calendar sales and PC wallpaper calendar release | https://www.nippon-shinyaku.co.jp/news/news.php?id=3534 |
| TSE:4530 | 11/17/2025 | Announcement of renewal of “Magneking® Bandage” | https://www.hisamitsu.co.jp/company/pdf/news_release_251117.pdf |